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Endomyocardial biopsy (EMB) is used at regular inter-
vals for the detection of allograft rejection after heart
transplantation (HTx). Many researchers have reported
tricuspid regurgitation (TR) caused by iatrogenic injury
during EMB. The incidence of moderate to severe TR
after HTx ranged from 6% to 32%, depending on the
institutional differences and the frequency of EMB.1,2
A histologic study on the evidence of tricuspid chordal
tissue during EMB showed that the incidence of chordal
injury by bioptome was as high as 47%.3 McGill
University’s data showed that 60% of patients with
more than 31 EMBs had developed severe TR, noting 
a direct correlation between the number of EMBs and
the severity of TR.4 Almost all (85–92%) of the patients
who survived up to 5–10 years after HTx were free
from TR.5 Although the immediate risk of TR is low,
the development of severe TR after HTx is associated
with high morbidity and significantly affects the long-
term outcome of patients.
From 1988 to 2006, this team has performed 274
cases of orthotopic HTx at Tri-Service General Hospital
and Cheng Hsin Rehabilitation Medical Center. The
average age of the recipients was 47.4±14.7 years
(range, 2.3–75 years) and the gender ratio was 206/68
(male/female). Excluding those who received HTx 
in the past 1 year (2006), 178 recipients are still alive.
Forty-seven of the 178 recipients (47/178, 26.4%)
developed moderate or severe TR after HTx. We stud-
ied the relationships among the number of EMBs, acute
cellular rejection (ACR), and TR:
1. Number of EMBs and TR: The average number of
EMBs in the TR group was 15.0 ± 6.4 (mean ± SD)
or 15 (0–42) (median [range]); and in the non-TR
group 14.6±5.9 or 15 (3–28) (Mann–Whitney test,
p = 0.69). As to the correlation between the TR
grading and number of EMBs, the ρ value was 
−0.012 (Spearman correlation test, p = 0.88).
2. ACR and TR: In those patients who had ACR
(grade 2 or higher), 25.9% had TR (moderate or
severe); and in those without ACR, 26.7% had TR.
Similarly, in those who had TR, 68.0% had ACR;
and in those without TR, 67.2% had ACR (Fisher’s
exact test, p = 0.50). To correlate the TR grading
and ACR grading, the ρ value was 0.02 (Spearman
correlation test, p = 0.45).
3. Number of EMBs and time to TR: Number of
EMBs and time to onset of TR showed significant
positive Spearman correlation (ρ=0.47; p=0.0008).
Our data revealed: (1) occurrence of TR after HTx was
not related to the number of EMBs that the recipient
received; (2) TR was not related to ACR; and (3) there
was positive correlation between the time of onset of
TR and the number of EMBs that the recipient
received.
The incidence of TR in our series was not as high
as those in the aforementioned reports. Although the
number of EMBs did not significantly correlate with 
the occurrence of TR, the greater the number of EMBs
performed after HTx, the earlier the development 
of TR. This phenomenon indicates that EMB is still 
a cause of TR, but has become not so obvious due to
the lower incidence of TR in our series. We have 12
full-time cardiologists at this hospital, but only 4 are
actively involved in performing EMBs; they are senior
cardiologists with ample experience, and thus the com-
plication rate is very low. This might explain the better
outcome in our series.
Atrial anastomotic technique is also a possible con-
tributing factor of TR after HTx. Some authors hold
the opinion that the standard Lowe and Shumway’s
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technique for atrial anastomosis may cause twisting of
the heart and result in atrioventricular valve incompe-
tence, and thus suggest bicaval anastomosis.6–8 In our
series, we applied the standard Lowe and Shumway’s
technique in every case, but did not find a higher inci-
dence of TR. We do not know the reason why, but
when we started to do left atrial anastomosis, we paid
much more attention to the symmetry of the recipient’s
and donor’s atria to avoid any torsion of the implanted
donor heart.
The incidence of TR after HTx in this manuscript
is much higher than many others in the published lite-
rature.9 The prevalence of moderate to severe TR was
25.6% immediately after HTx and was as high as 61.5%
at the end of the follow-up period. With the average
biopsy episodes of <10 for each recipient, the incidence
of TR is too high, relatively. Further investigation of
the pathogenesis of these results is advised.
In summary, TR caused by iatrogenic trauma during
EMB and after HTx is common. To achieve better life
quality and longer life span for the recipients, I sug-
gest decreasing the frequency of biopsy to reduce the
risk of such complication. Before less traumatic diag-
nostic tools are available, EMB must be considered to
be a serious procedure and should be performed by
experienced cardiologists only.
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